Study Title
Phase 3 Randomized Trial Comparing Overall Survival After Photon versus Proton Chemoradiotherapy for Inoperable Stage II-IIIB Non-Small Cell Lung Cancer (NSCLC)
Purpose
To compare the good and bad effects in terms of patient life span after these 2 different types of radiation therapy (photon versus proton) in combination with FDA-approved chemotherapy for lung cancer. This study will allow the researchers to know whether the proton therapy approach is better, the same, or worse then the usual photon approach in terms of survival.
Eligibility
Study Process
Trial Details
Investigator:
IRB:
National Cancer Institute led by NRG Oncology
IRB Number:
Trial Type:
NA
Sponsor:
National Cancer Institute led by NRG Oncology
Contact Information:
Radiation Oncology Services